Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Unlike the so-called acquired immune system, with its disease-fighting cells and antibodies, innate immunity depends on peptides and small proteins to fight off dangerous microbes. As genomic information has flooded out of sequencing labs within the last few years, researchers have identified hundreds of these peptides from a broad range of species. They are also now working out exactly what trips these defenses and how they specialize to fight off the pathogens that attack each kind of organism--information that may make peptides a new source of antibiotics.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
NEWS FOCUS
Trisha Gura (16 March 2001) Science291 (5511), 2070.
[DOI: 10.1126/science.291.5511.2070] |Summary »|Full Text »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
ST2 Is Essential for Th2 Responsiveness and Resistance to Pseudomonas aeruginosa Keratitis.
X. Huang, W. Du, R. P. Barrett, and L. D. Hazlett (2007)
Invest. Ophthalmol. Vis. Sci.
48, 4626-4633
|Abstract »|Full Text »|PDF »
Babesial Vector Tick Defensin against Babesia sp. Parasites.
N. Tsuji, B. Battsetseg, D. Boldbaatar, T. Miyoshi, X. Xuan, J. H. Oliver Jr., and K. Fujisaki (2007)
Infect. Immun.
75, 3633-3640
|Abstract »|Full Text »|PDF »
Antiplasmodial Activity of Lauryl-Lysine Oligomers.
I. Radzishevsky, M. Krugliak, H. Ginsburg, and A. Mor (2007)
Antimicrob. Agents Chemother.
51, 1753-1759
|Abstract »|Full Text »|PDF »
Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection.
F. E. Lopez, P. A. Vincent, A. M. Zenoff, R. A. Salomon, and R. N. Farias (2007)
J. Antimicrob. Chemother.
59, 676-680
|Abstract »|Full Text »|PDF »
Direct Interaction of Dermaseptin S4 Aminoheptanoyl Derivative with Intraerythrocytic Malaria Parasite Leading to Increased Specific Antiparasitic Activity in Culture.
L. Efron, A. Dagan, L. Gaidukov, H. Ginsburg, and A. Mor (2002)
J. Biol. Chem.
277, 24067-24072
|Abstract »|Full Text »|PDF »
Structural Requirements for Potent Versus Selective Cytotoxicity for Antimicrobial Dermaseptin S4 Derivatives.
I. Kustanovich, D. E. Shalev, M. Mikhlin, L. Gaidukov, and A. Mor (2002)
J. Biol. Chem.
277, 16941-16951
|Abstract »|Full Text »|PDF »
In Vitro Antiplasmodium Effects of Dermaseptin S4 Derivatives.
A. Dagan, L. Efron, L. Gaidukov, A. Mor, and H. Ginsburg (2002)
Antimicrob. Agents Chemother.
46, 1059-1066
|Abstract »|Full Text »|PDF »
Antibacterial Properties of Dermaseptin S4 Derivatives with In Vivo Activity.
S. Navon-Venezia, R. Feder, L. Gaidukov, Y. Carmeli, and A. Mor (2002)
Antimicrob. Agents Chemother.
46, 689-694
|Abstract »|Full Text »|PDF »
In Vitro Susceptibility to Thrombin-Induced Platelet Microbicidal Protein Is Associated With Reduced Disease Progression and Complication Rates in Experimental Staphylococcus aureus Endocarditis: Microbiological, Histopathologic, and Echocardiographic Analyses.
L. I. Kupferwasser, M. R. Yeaman, S. M. Shapiro, C. C. Nast, and A. S. Bayer (2002)
Circulation
105, 746-752
|Abstract »|Full Text »|PDF »